# NeoVas Bioresorbable Coronary Scaffold First-in-Man Study

> **NCT02195414** · PHASE1 · UNKNOWN · sponsor: **Lepu Medical Technology (Beijing) Co., Ltd.** · enrollment: 31 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** NeoVas BCS

## Key facts

- **NCT ID:** NCT02195414
- **Lead sponsor:** Lepu Medical Technology (Beijing) Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-07
- **Primary completion:** 2014-11
- **Final completion:** 2019-09
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2016-04-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02195414

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02195414, "NeoVas Bioresorbable Coronary Scaffold First-in-Man Study". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02195414. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*